Drug delivery companies develop technologies, formulations and platforms that control how, where and when therapeutic agents are released in the body. The field focuses on improving treatment efficacy, reducing side effects and helping medicines reach their intended targets safely and efficiently.
This category includes companies working on:
Browse 103 UK drug delivery companies below.
Long-acting eye-drop matrix technology for chronic ocular surface disease
Healome Therapeutics is a University of Birmingham spin-out developing a proprietary eye-drop matrix technology that improves drug retention, lubrication and healing on the eye…
Small molecule drug discovery focused on fibrosis and oncology
Redx Pharma is a clinical-stage biotech developing novel small molecule therapeutics for fibrotic disease and cancer. Its pipeline is anchored by zelasudil, a selective ROCK2…
Integrated drug discovery, development and GMP manufacturing CRO
Concept Life Sciences is a contract research organisation delivering integrated drug discovery, development and GMP manufacturing services across facilities in Chapel-en-le-Frith,…
Needle-free solid dose vaccine formulation and delivery platform
aVaxMed Limited is a UK biotech developing the aVaxziPen platform, a proprietary needle-free, thermally stable, solid dose vaccine delivery system. The technology encapsulates…
Nanotechnology drug delivery platform for precision medicines
Nanomerics is a UK speciality pharmaceutical company developing precision medicines using its proprietary technology, a polymer nanotechnology platform that improves the…
Bioactive molecule delivery technologies for cell culture and therapeutics
Cell Guidance Systems is a biotech and reagents company developing technologies for the delivery of bioactive molecules, with applications in cell biology research, drug…
Targeted lipid nanoparticle delivery platform for precision therapeutics
Hone Bio is a preclinical biotechnology company developing targeted lipid nanoparticle drug delivery technology. Its proprietary platform uses engineered proteins that enable…
RBC derived nanoparticles for RNA delivery to brain and immune cells
Crane Biosciences is a biotechnology company developing a non-immunogenic RNA delivery platform based on nanoparticles derived from red blood cell membranes. By using the body's…
Stem cell-derived exosome platform for targeted drug delivery
ReNeuron is a biotechnology company developing a stem cell-derived exosome platform for targeted therapeutic delivery. Founded on over two decades of stem cell science, including…
Global CDMO for drug development, delivery and manufacture
Catalent Pharma Solutions is a contract development and manufacturing organisation providing drug development, formulation, and manufacturing services across small molecules,…
Clinical trial supply, packaging and distribution services
Sharp Services is a contract development and manufacturing organisation providing clinical supply chain services for pharmaceutical and biotechnology companies. Operating from an…
LNP-mRNA growth factor therapy to restore hearing loss
CamGene Therapeutics is a preclinical biotechnology company developing lipid nanoparticle-delivered mRNA medicines to treat hearing loss at its underlying cellular cause. Its lead…